1. Search Result

Search Result

Targets Recommended: Ack1

Results for "141206-42-0" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-106392
    Lucerastat

    NB-DGJ; N-(n-Butyl)deoxygalactonojirimycin

    Others Metabolic Disease
    Lucerastat, the galactose form of Miglustat, is an orally-available inhibitor of glucosylceramide synthase (GCS). Lucerastat has the potential for Fabry disease study.